ELF4 and neoplasm: We found that the median age of the patients with tumours that expressed higher ELF4 was significantly higher (median = 63 years) compared to that of patients with tumours that expressed lower levels of ELF4 (median = 58 years), Wilcoxon rank-sum test (Z = 119.2, p < 1 x 10−300; Fig 1D).